KIMBERLY POPE: Open Payments
NPI 1184800815 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,060 in 51 payments from 13 companies in 2025. Trend: 2023 $434 · 2024 $1,008 · 2025 $1,060
Food & beverage: $1,060
| Company | Payments | Amount |
|---|---|---|
| MDD US Operations, LLC | 7 | $166 |
| PFIZER INC. | 14 | $138 |
| ARGENX US, INC. | 4 | $106 |
| SK Life Science, Inc. | 4 | $104 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $96 |
| Biogen, Inc. | 4 | $94 |
| ABBVIE INC. | 4 | $85 |
| UCB, Inc. | 2 | $64 |
| Genentech USA, Inc. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $57 |
Products named: NURTEC ODT, VYVGART HYTRULO, JOURNAVX, Qelbree, Gocovri, TYSABRI, Ocrevus Zunovo, REXULTI.
Industry payments across NV — which companies pay providers there.
